Three-Year Follow-Up From Checkmate 017/057: Nivolumab Versus Docetaxel In Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (Nsclc) Enriqueta Felip,Scott Gettinger, Marco Angelo Burgio,Scott J. Antonia,Esther Holgado,David Spigel,Oscar Arrieta,Manuel Domine,Osvaldo Aren Frontera,Julie Brahmer, Laura Q. Chow,Lucio Crino,Charles Butts,Bruno Coudert,Leora Horn,Martin Steins,William J. Geese,Ang Li,Diane Healey,Everett E. VokesANNALS OF ONCOLOGY（2017）引用 17|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
